Advice on the financing and strategy of a company focused on the analysis of blood disorders using a medical device.
Summary
ST strategy advises the company once the tests began and the prototype of the device was developed with a consolidated management team and 9 people in the operational team. Advised on the capital increase and the company’s strategy.
Companies in the healthcare sector have improved exponentially, in terms of innovation, in the last 10 years and the trend is on the same way. One of the main lines of study is blood disorders.
In this case, the company BloodDiagnostics* was able, a few years ago, to perfectly understand the need to create a solution that would detect blood alterations in less than 5 minutes.
ST strategy helped the company once the trials began and the device was developed. Advised on the capital increase and the company’s strategy.
Medical Device
Capital to start commercialization
Health innovation
The complete story
Opportunity
After several market studies and emerging as an initiative of one of the most cutting-edge mathematical Research Parks in Spain, the company developed a medical device that generated a significant disruption.
The device was capable of analyzing blood alterations in less than 5 minutes, without any type of invasion towards the person being treated, without the use of biomarkers and the evaluation of blood counts.
It was a patented technology, which allowed low-cost results to be obtained in a short time and with a view to become a large database for the market.
The company was searching for advice at this stage of the process regarding its financing and the commercial strategy of the business.
Recommendations
Based on the analysis carried out, a series of actions were designed to provide the company with a management team, a roadmap with targets identified in commercial terms and the financing that would allow the expected growth.
- Internal organization: Although the structure was minimal but efficient, the truth is that it needed to be reinforced to face the projected growth with guarantees. It was necessary to reorganize the staff and generate new protocols.
- Commercial objectives: Although the company was in the validation phase, all the lines of business (basically two) were defined in order to argue the company’s fit and success in the market.
- Documentation: All the necessary documents were prepared to go on the market and be able to carry out the subsequent capital increase (Information Memorandum, Business Plan, Valuation, Screening and Teaser).
* The confidentiality of our clients is a priority of the company. Although we have changed their names, the information is real